Global Newborn Disease Screening Market Growth (Status and Outlook) 2026-2032
The global Newborn Disease Screening market size is predicted to grow from US$ 1061 million in 2025 to US$ 1615 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Newborn Disease Screening is the organized process of testing infants shortly after birth to identify serious conditions that are not obvious at the time of delivery but can cause severe harm if not treated early. It encompasses sample collection, laboratory screening for selected disorders, communication of results to caregivers and clinicians, confirmatory testing for abnormal findings, and referral into timely treatment and long term follow up care pathways.
The newborn disease screening market is best viewed as a mission critical component of maternal and child health systems with demand anchored by universal clinical need and public health mandates rather than discretionary utilization. Market evolution is driven primarily by program scope expansion, improvements in analytical performance, and modernization of operational workflows such as automation, digital reporting, and coordinated follow up. Competitive dynamics tend to favor incumbent laboratories and technology suppliers that can demonstrate long term reliability, regulatory compliance, and interoperability with hospital and public health information systems, creating high barriers for new entrants and limiting price led disruption. As the field advances, the key strategic tension is balancing broader disease coverage with evidence of clinical utility and system capacity for confirmatory testing and treatment, making governance alignment and downstream care readiness as important as the screening technology itself.
LPI (LP Information)' newest research report, the “Newborn Disease Screening Industry Forecast” looks at past sales and reviews total world Newborn Disease Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Newborn Disease Screening sales for 2026 through 2032. With Newborn Disease Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn Disease Screening industry.
This Insight Report provides a comprehensive analysis of the global Newborn Disease Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn Disease Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn Disease Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn Disease Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn Disease Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn Disease Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Newborn Disease Screening is the organized process of testing infants shortly after birth to identify serious conditions that are not obvious at the time of delivery but can cause severe harm if not treated early. It encompasses sample collection, laboratory screening for selected disorders, communication of results to caregivers and clinicians, confirmatory testing for abnormal findings, and referral into timely treatment and long term follow up care pathways.
The newborn disease screening market is best viewed as a mission critical component of maternal and child health systems with demand anchored by universal clinical need and public health mandates rather than discretionary utilization. Market evolution is driven primarily by program scope expansion, improvements in analytical performance, and modernization of operational workflows such as automation, digital reporting, and coordinated follow up. Competitive dynamics tend to favor incumbent laboratories and technology suppliers that can demonstrate long term reliability, regulatory compliance, and interoperability with hospital and public health information systems, creating high barriers for new entrants and limiting price led disruption. As the field advances, the key strategic tension is balancing broader disease coverage with evidence of clinical utility and system capacity for confirmatory testing and treatment, making governance alignment and downstream care readiness as important as the screening technology itself.
LPI (LP Information)' newest research report, the “Newborn Disease Screening Industry Forecast” looks at past sales and reviews total world Newborn Disease Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Newborn Disease Screening sales for 2026 through 2032. With Newborn Disease Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn Disease Screening industry.
This Insight Report provides a comprehensive analysis of the global Newborn Disease Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn Disease Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn Disease Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn Disease Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn Disease Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn Disease Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Genetic Sequencing
- Hearing Screening
- Pulse Oximetry
- Others
- Core Condition Screening
- Expanded Condition Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Cordlife
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Disease Screening Market Size (2021-2032)
2.1.2 Newborn Disease Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Newborn Disease Screening by Country/Region (2021, 2025 & 2032)
2.2 Newborn Disease Screening Segment by Type
2.2.1 Genetic Sequencing
2.2.2 Hearing Screening
2.2.3 Pulse Oximetry
2.2.4 Others
2.2.5 Newborn Disease Screening Market Size by Type
2.2.5.1 Newborn Disease Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Newborn Disease Screening Market Size Market Share by Type (2021-2026)
2.3 Newborn Disease Screening Segment by Screening Purpose
2.3.1 Core Condition Screening
2.3.2 Expanded Condition Screening
2.3.3 Newborn Disease Screening Market Size by Screening Purpose
2.3.3.1 Newborn Disease Screening Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032)
2.3.3.2 Global Newborn Disease Screening Market Size Market Share by Screening Purpose (2021-2026)
2.4 Newborn Disease Screening Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Newborn Disease Screening Market Size by Service Model
2.4.4.1 Newborn Disease Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Newborn Disease Screening Market Size Market Share by Service Model (2021-2026)
2.5 Newborn Disease Screening Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Others
2.5.4 Newborn Disease Screening Market Size by Application
2.5.4.1 Newborn Disease Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Newborn Disease Screening Market Size Market Share by Application (2021-2026)
3 NEWBORN DISEASE SCREENING MARKET SIZE BY PLAYER
3.1 Newborn Disease Screening Market Size Market Share by Player
3.1.1 Global Newborn Disease Screening Revenue by Player (2021-2026)
3.1.2 Global Newborn Disease Screening Revenue Market Share by Player (2021-2026)
3.2 Global Newborn Disease Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN DISEASE SCREENING BY REGION
4.1 Newborn Disease Screening Market Size by Region (2021-2026)
4.2 Global Newborn Disease Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newborn Disease Screening Market Size Growth (2021-2026)
4.4 APAC Newborn Disease Screening Market Size Growth (2021-2026)
4.5 Europe Newborn Disease Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Newborn Disease Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Newborn Disease Screening Market Size by Country (2021-2026)
5.2 Americas Newborn Disease Screening Market Size by Type (2021-2026)
5.3 Americas Newborn Disease Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Disease Screening Market Size by Region (2021-2026)
6.2 APAC Newborn Disease Screening Market Size by Type (2021-2026)
6.3 APAC Newborn Disease Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Disease Screening Market Size by Country (2021-2026)
7.2 Europe Newborn Disease Screening Market Size by Type (2021-2026)
7.3 Europe Newborn Disease Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Disease Screening by Region (2021-2026)
8.2 Middle East & Africa Newborn Disease Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Newborn Disease Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN DISEASE SCREENING MARKET FORECAST
10.1 Global Newborn Disease Screening Forecast by Region (2027-2032)
10.1.1 Global Newborn Disease Screening Forecast by Region (2027-2032)
10.1.2 Americas Newborn Disease Screening Forecast
10.1.3 APAC Newborn Disease Screening Forecast
10.1.4 Europe Newborn Disease Screening Forecast
10.1.5 Middle East & Africa Newborn Disease Screening Forecast
10.2 Americas Newborn Disease Screening Forecast by Country (2027-2032)
10.2.1 United States Market Newborn Disease Screening Forecast
10.2.2 Canada Market Newborn Disease Screening Forecast
10.2.3 Mexico Market Newborn Disease Screening Forecast
10.2.4 Brazil Market Newborn Disease Screening Forecast
10.3 APAC Newborn Disease Screening Forecast by Region (2027-2032)
10.3.1 China Newborn Disease Screening Market Forecast
10.3.2 Japan Market Newborn Disease Screening Forecast
10.3.3 Korea Market Newborn Disease Screening Forecast
10.3.4 Southeast Asia Market Newborn Disease Screening Forecast
10.3.5 India Market Newborn Disease Screening Forecast
10.3.6 Australia Market Newborn Disease Screening Forecast
10.4 Europe Newborn Disease Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Newborn Disease Screening Forecast
10.4.2 France Market Newborn Disease Screening Forecast
10.4.3 UK Market Newborn Disease Screening Forecast
10.4.4 Italy Market Newborn Disease Screening Forecast
10.4.5 Russia Market Newborn Disease Screening Forecast
10.5 Middle East & Africa Newborn Disease Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Newborn Disease Screening Forecast
10.5.2 South Africa Market Newborn Disease Screening Forecast
10.5.3 Israel Market Newborn Disease Screening Forecast
10.5.4 Turkey Market Newborn Disease Screening Forecast
10.6 Global Newborn Disease Screening Forecast by Type (2027-2032)
10.7 Global Newborn Disease Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Newborn Disease Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Newborn Disease Screening Product Offered
11.1.3 Thermo Fisher Scientific Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Revvity
11.2.1 Revvity Company Information
11.2.2 Revvity Newborn Disease Screening Product Offered
11.2.3 Revvity Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Revvity Main Business Overview
11.2.5 Revvity Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Newborn Disease Screening Product Offered
11.3.3 Quest Diagnostics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Newborn Disease Screening Product Offered
11.4.3 MedGenome Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Newborn Disease Screening Product Offered
11.5.3 Mayo Clinic Laboratories Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 GeneDx
11.6.1 GeneDx Company Information
11.6.2 GeneDx Newborn Disease Screening Product Offered
11.6.3 GeneDx Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GeneDx Main Business Overview
11.6.5 GeneDx Latest Developments
11.7 PreventionGenetics
11.7.1 PreventionGenetics Company Information
11.7.2 PreventionGenetics Newborn Disease Screening Product Offered
11.7.3 PreventionGenetics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 PreventionGenetics Main Business Overview
11.7.5 PreventionGenetics Latest Developments
11.8 SYNLAB
11.8.1 SYNLAB Company Information
11.8.2 SYNLAB Newborn Disease Screening Product Offered
11.8.3 SYNLAB Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SYNLAB Main Business Overview
11.8.5 SYNLAB Latest Developments
11.9 Cordlife
11.9.1 Cordlife Company Information
11.9.2 Cordlife Newborn Disease Screening Product Offered
11.9.3 Cordlife Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cordlife Main Business Overview
11.9.5 Cordlife Latest Developments
11.10 BGI Genomics
11.10.1 BGI Genomics Company Information
11.10.2 BGI Genomics Newborn Disease Screening Product Offered
11.10.3 BGI Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BGI Genomics Main Business Overview
11.10.5 BGI Genomics Latest Developments
11.11 Berry Genomics
11.11.1 Berry Genomics Company Information
11.11.2 Berry Genomics Newborn Disease Screening Product Offered
11.11.3 Berry Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Berry Genomics Main Business Overview
11.11.5 Berry Genomics Latest Developments
11.12 Annaroad
11.12.1 Annaroad Company Information
11.12.2 Annaroad Newborn Disease Screening Product Offered
11.12.3 Annaroad Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Annaroad Main Business Overview
11.12.5 Annaroad Latest Developments
11.13 Jiajian Medical Testing
11.13.1 Jiajian Medical Testing Company Information
11.13.2 Jiajian Medical Testing Newborn Disease Screening Product Offered
11.13.3 Jiajian Medical Testing Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Jiajian Medical Testing Main Business Overview
11.13.5 Jiajian Medical Testing Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Newborn Disease Screening Product Offered
11.14.3 Genesky Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Newborn Disease Screening Product Offered
11.15.3 Weihansi Biomedical Technology Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newborn Disease Screening Market Size (2021-2032)
2.1.2 Newborn Disease Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Newborn Disease Screening by Country/Region (2021, 2025 & 2032)
2.2 Newborn Disease Screening Segment by Type
2.2.1 Genetic Sequencing
2.2.2 Hearing Screening
2.2.3 Pulse Oximetry
2.2.4 Others
2.2.5 Newborn Disease Screening Market Size by Type
2.2.5.1 Newborn Disease Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Newborn Disease Screening Market Size Market Share by Type (2021-2026)
2.3 Newborn Disease Screening Segment by Screening Purpose
2.3.1 Core Condition Screening
2.3.2 Expanded Condition Screening
2.3.3 Newborn Disease Screening Market Size by Screening Purpose
2.3.3.1 Newborn Disease Screening Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032)
2.3.3.2 Global Newborn Disease Screening Market Size Market Share by Screening Purpose (2021-2026)
2.4 Newborn Disease Screening Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Newborn Disease Screening Market Size by Service Model
2.4.4.1 Newborn Disease Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Newborn Disease Screening Market Size Market Share by Service Model (2021-2026)
2.5 Newborn Disease Screening Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Others
2.5.4 Newborn Disease Screening Market Size by Application
2.5.4.1 Newborn Disease Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Newborn Disease Screening Market Size Market Share by Application (2021-2026)
3 NEWBORN DISEASE SCREENING MARKET SIZE BY PLAYER
3.1 Newborn Disease Screening Market Size Market Share by Player
3.1.1 Global Newborn Disease Screening Revenue by Player (2021-2026)
3.1.2 Global Newborn Disease Screening Revenue Market Share by Player (2021-2026)
3.2 Global Newborn Disease Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEWBORN DISEASE SCREENING BY REGION
4.1 Newborn Disease Screening Market Size by Region (2021-2026)
4.2 Global Newborn Disease Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newborn Disease Screening Market Size Growth (2021-2026)
4.4 APAC Newborn Disease Screening Market Size Growth (2021-2026)
4.5 Europe Newborn Disease Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Newborn Disease Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Newborn Disease Screening Market Size by Country (2021-2026)
5.2 Americas Newborn Disease Screening Market Size by Type (2021-2026)
5.3 Americas Newborn Disease Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newborn Disease Screening Market Size by Region (2021-2026)
6.2 APAC Newborn Disease Screening Market Size by Type (2021-2026)
6.3 APAC Newborn Disease Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Newborn Disease Screening Market Size by Country (2021-2026)
7.2 Europe Newborn Disease Screening Market Size by Type (2021-2026)
7.3 Europe Newborn Disease Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newborn Disease Screening by Region (2021-2026)
8.2 Middle East & Africa Newborn Disease Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Newborn Disease Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEWBORN DISEASE SCREENING MARKET FORECAST
10.1 Global Newborn Disease Screening Forecast by Region (2027-2032)
10.1.1 Global Newborn Disease Screening Forecast by Region (2027-2032)
10.1.2 Americas Newborn Disease Screening Forecast
10.1.3 APAC Newborn Disease Screening Forecast
10.1.4 Europe Newborn Disease Screening Forecast
10.1.5 Middle East & Africa Newborn Disease Screening Forecast
10.2 Americas Newborn Disease Screening Forecast by Country (2027-2032)
10.2.1 United States Market Newborn Disease Screening Forecast
10.2.2 Canada Market Newborn Disease Screening Forecast
10.2.3 Mexico Market Newborn Disease Screening Forecast
10.2.4 Brazil Market Newborn Disease Screening Forecast
10.3 APAC Newborn Disease Screening Forecast by Region (2027-2032)
10.3.1 China Newborn Disease Screening Market Forecast
10.3.2 Japan Market Newborn Disease Screening Forecast
10.3.3 Korea Market Newborn Disease Screening Forecast
10.3.4 Southeast Asia Market Newborn Disease Screening Forecast
10.3.5 India Market Newborn Disease Screening Forecast
10.3.6 Australia Market Newborn Disease Screening Forecast
10.4 Europe Newborn Disease Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Newborn Disease Screening Forecast
10.4.2 France Market Newborn Disease Screening Forecast
10.4.3 UK Market Newborn Disease Screening Forecast
10.4.4 Italy Market Newborn Disease Screening Forecast
10.4.5 Russia Market Newborn Disease Screening Forecast
10.5 Middle East & Africa Newborn Disease Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Newborn Disease Screening Forecast
10.5.2 South Africa Market Newborn Disease Screening Forecast
10.5.3 Israel Market Newborn Disease Screening Forecast
10.5.4 Turkey Market Newborn Disease Screening Forecast
10.6 Global Newborn Disease Screening Forecast by Type (2027-2032)
10.7 Global Newborn Disease Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Newborn Disease Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Newborn Disease Screening Product Offered
11.1.3 Thermo Fisher Scientific Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Revvity
11.2.1 Revvity Company Information
11.2.2 Revvity Newborn Disease Screening Product Offered
11.2.3 Revvity Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Revvity Main Business Overview
11.2.5 Revvity Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Newborn Disease Screening Product Offered
11.3.3 Quest Diagnostics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Newborn Disease Screening Product Offered
11.4.3 MedGenome Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Newborn Disease Screening Product Offered
11.5.3 Mayo Clinic Laboratories Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 GeneDx
11.6.1 GeneDx Company Information
11.6.2 GeneDx Newborn Disease Screening Product Offered
11.6.3 GeneDx Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 GeneDx Main Business Overview
11.6.5 GeneDx Latest Developments
11.7 PreventionGenetics
11.7.1 PreventionGenetics Company Information
11.7.2 PreventionGenetics Newborn Disease Screening Product Offered
11.7.3 PreventionGenetics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 PreventionGenetics Main Business Overview
11.7.5 PreventionGenetics Latest Developments
11.8 SYNLAB
11.8.1 SYNLAB Company Information
11.8.2 SYNLAB Newborn Disease Screening Product Offered
11.8.3 SYNLAB Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SYNLAB Main Business Overview
11.8.5 SYNLAB Latest Developments
11.9 Cordlife
11.9.1 Cordlife Company Information
11.9.2 Cordlife Newborn Disease Screening Product Offered
11.9.3 Cordlife Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cordlife Main Business Overview
11.9.5 Cordlife Latest Developments
11.10 BGI Genomics
11.10.1 BGI Genomics Company Information
11.10.2 BGI Genomics Newborn Disease Screening Product Offered
11.10.3 BGI Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BGI Genomics Main Business Overview
11.10.5 BGI Genomics Latest Developments
11.11 Berry Genomics
11.11.1 Berry Genomics Company Information
11.11.2 Berry Genomics Newborn Disease Screening Product Offered
11.11.3 Berry Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Berry Genomics Main Business Overview
11.11.5 Berry Genomics Latest Developments
11.12 Annaroad
11.12.1 Annaroad Company Information
11.12.2 Annaroad Newborn Disease Screening Product Offered
11.12.3 Annaroad Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Annaroad Main Business Overview
11.12.5 Annaroad Latest Developments
11.13 Jiajian Medical Testing
11.13.1 Jiajian Medical Testing Company Information
11.13.2 Jiajian Medical Testing Newborn Disease Screening Product Offered
11.13.3 Jiajian Medical Testing Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Jiajian Medical Testing Main Business Overview
11.13.5 Jiajian Medical Testing Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Newborn Disease Screening Product Offered
11.14.3 Genesky Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Newborn Disease Screening Product Offered
11.15.3 Weihansi Biomedical Technology Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Newborn Disease Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Newborn Disease Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Sequencing
Table 4. Major Players of Hearing Screening
Table 5. Major Players of Pulse Oximetry
Table 6. Major Players of Others
Table 7. Newborn Disease Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Core Condition Screening
Table 11. Major Players of Expanded Condition Screening
Table 12. Newborn Disease Screening Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Newborn Disease Screening Market Size by Screening Purpose (2021-2026) & ($ millions)
Table 14. Global Newborn Disease Screening Market Size Market Share by Screening Purpose (2021-2026)
Table 15. Major Players of Public Health Program
Table 16. Major Players of Consumer
Table 17. Major Players of Others
Table 18. Newborn Disease Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Newborn Disease Screening Market Size by Service Model (2021-2026) & ($ millions)
Table 20. Global Newborn Disease Screening Market Size Market Share by Service Model (2021-2026)
Table 21. Newborn Disease Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Table 24. Global Newborn Disease Screening Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Newborn Disease Screening Revenue Market Share by Player (2021-2026)
Table 26. Newborn Disease Screening Key Players Head office and Products Offered
Table 27. Newborn Disease Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Table 32. Global Newborn Disease Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Newborn Disease Screening Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Newborn Disease Screening Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Newborn Disease Screening Market Size Market Share by Country (2021-2026)
Table 36. Americas Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Table 38. Americas Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Table 40. APAC Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Table 42. APAC Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Newborn Disease Screening Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Newborn Disease Screening Market Size Market Share by Country (2021-2026)
Table 46. Europe Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Newborn Disease Screening
Table 52. Key Market Challenges & Risks of Newborn Disease Screening
Table 53. Key Industry Trends of Newborn Disease Screening
Table 54. Global Newborn Disease Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Newborn Disease Screening Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Newborn Disease Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Newborn Disease Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Newborn Disease Screening Product Offered
Table 60. Thermo Fisher Scientific Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Revvity Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 64. Revvity Newborn Disease Screening Product Offered
Table 65. Revvity Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Revvity Main Business
Table 67. Revvity Latest Developments
Table 68. Quest Diagnostics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 69. Quest Diagnostics Newborn Disease Screening Product Offered
Table 70. Quest Diagnostics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Quest Diagnostics Main Business
Table 72. Quest Diagnostics Latest Developments
Table 73. MedGenome Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 74. MedGenome Newborn Disease Screening Product Offered
Table 75. MedGenome Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. MedGenome Main Business
Table 77. MedGenome Latest Developments
Table 78. Mayo Clinic Laboratories Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 79. Mayo Clinic Laboratories Newborn Disease Screening Product Offered
Table 80. Mayo Clinic Laboratories Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Mayo Clinic Laboratories Main Business
Table 82. Mayo Clinic Laboratories Latest Developments
Table 83. GeneDx Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 84. GeneDx Newborn Disease Screening Product Offered
Table 85. GeneDx Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. GeneDx Main Business
Table 87. GeneDx Latest Developments
Table 88. PreventionGenetics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 89. PreventionGenetics Newborn Disease Screening Product Offered
Table 90. PreventionGenetics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. PreventionGenetics Main Business
Table 92. PreventionGenetics Latest Developments
Table 93. SYNLAB Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 94. SYNLAB Newborn Disease Screening Product Offered
Table 95. SYNLAB Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. SYNLAB Main Business
Table 97. SYNLAB Latest Developments
Table 98. Cordlife Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 99. Cordlife Newborn Disease Screening Product Offered
Table 100. Cordlife Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Cordlife Main Business
Table 102. Cordlife Latest Developments
Table 103. BGI Genomics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 104. BGI Genomics Newborn Disease Screening Product Offered
Table 105. BGI Genomics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. BGI Genomics Main Business
Table 107. BGI Genomics Latest Developments
Table 108. Berry Genomics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 109. Berry Genomics Newborn Disease Screening Product Offered
Table 110. Berry Genomics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Berry Genomics Main Business
Table 112. Berry Genomics Latest Developments
Table 113. Annaroad Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 114. Annaroad Newborn Disease Screening Product Offered
Table 115. Annaroad Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Annaroad Main Business
Table 117. Annaroad Latest Developments
Table 118. Jiajian Medical Testing Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 119. Jiajian Medical Testing Newborn Disease Screening Product Offered
Table 120. Jiajian Medical Testing Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Jiajian Medical Testing Main Business
Table 122. Jiajian Medical Testing Latest Developments
Table 123. Genesky Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 124. Genesky Newborn Disease Screening Product Offered
Table 125. Genesky Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Genesky Main Business
Table 127. Genesky Latest Developments
Table 128. Weihansi Biomedical Technology Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 129. Weihansi Biomedical Technology Newborn Disease Screening Product Offered
Table 130. Weihansi Biomedical Technology Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Weihansi Biomedical Technology Main Business
Table 132. Weihansi Biomedical Technology Latest Developments
Table 1. Newborn Disease Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Newborn Disease Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Sequencing
Table 4. Major Players of Hearing Screening
Table 5. Major Players of Pulse Oximetry
Table 6. Major Players of Others
Table 7. Newborn Disease Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Core Condition Screening
Table 11. Major Players of Expanded Condition Screening
Table 12. Newborn Disease Screening Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Newborn Disease Screening Market Size by Screening Purpose (2021-2026) & ($ millions)
Table 14. Global Newborn Disease Screening Market Size Market Share by Screening Purpose (2021-2026)
Table 15. Major Players of Public Health Program
Table 16. Major Players of Consumer
Table 17. Major Players of Others
Table 18. Newborn Disease Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Newborn Disease Screening Market Size by Service Model (2021-2026) & ($ millions)
Table 20. Global Newborn Disease Screening Market Size Market Share by Service Model (2021-2026)
Table 21. Newborn Disease Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Table 24. Global Newborn Disease Screening Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Newborn Disease Screening Revenue Market Share by Player (2021-2026)
Table 26. Newborn Disease Screening Key Players Head office and Products Offered
Table 27. Newborn Disease Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Table 32. Global Newborn Disease Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Newborn Disease Screening Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Newborn Disease Screening Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Newborn Disease Screening Market Size Market Share by Country (2021-2026)
Table 36. Americas Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Table 38. Americas Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Table 40. APAC Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Table 42. APAC Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Newborn Disease Screening Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Newborn Disease Screening Market Size Market Share by Country (2021-2026)
Table 46. Europe Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Newborn Disease Screening Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Newborn Disease Screening Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Newborn Disease Screening Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Newborn Disease Screening
Table 52. Key Market Challenges & Risks of Newborn Disease Screening
Table 53. Key Industry Trends of Newborn Disease Screening
Table 54. Global Newborn Disease Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Newborn Disease Screening Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Newborn Disease Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Newborn Disease Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Newborn Disease Screening Product Offered
Table 60. Thermo Fisher Scientific Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Revvity Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 64. Revvity Newborn Disease Screening Product Offered
Table 65. Revvity Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Revvity Main Business
Table 67. Revvity Latest Developments
Table 68. Quest Diagnostics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 69. Quest Diagnostics Newborn Disease Screening Product Offered
Table 70. Quest Diagnostics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Quest Diagnostics Main Business
Table 72. Quest Diagnostics Latest Developments
Table 73. MedGenome Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 74. MedGenome Newborn Disease Screening Product Offered
Table 75. MedGenome Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. MedGenome Main Business
Table 77. MedGenome Latest Developments
Table 78. Mayo Clinic Laboratories Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 79. Mayo Clinic Laboratories Newborn Disease Screening Product Offered
Table 80. Mayo Clinic Laboratories Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Mayo Clinic Laboratories Main Business
Table 82. Mayo Clinic Laboratories Latest Developments
Table 83. GeneDx Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 84. GeneDx Newborn Disease Screening Product Offered
Table 85. GeneDx Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. GeneDx Main Business
Table 87. GeneDx Latest Developments
Table 88. PreventionGenetics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 89. PreventionGenetics Newborn Disease Screening Product Offered
Table 90. PreventionGenetics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. PreventionGenetics Main Business
Table 92. PreventionGenetics Latest Developments
Table 93. SYNLAB Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 94. SYNLAB Newborn Disease Screening Product Offered
Table 95. SYNLAB Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. SYNLAB Main Business
Table 97. SYNLAB Latest Developments
Table 98. Cordlife Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 99. Cordlife Newborn Disease Screening Product Offered
Table 100. Cordlife Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Cordlife Main Business
Table 102. Cordlife Latest Developments
Table 103. BGI Genomics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 104. BGI Genomics Newborn Disease Screening Product Offered
Table 105. BGI Genomics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. BGI Genomics Main Business
Table 107. BGI Genomics Latest Developments
Table 108. Berry Genomics Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 109. Berry Genomics Newborn Disease Screening Product Offered
Table 110. Berry Genomics Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Berry Genomics Main Business
Table 112. Berry Genomics Latest Developments
Table 113. Annaroad Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 114. Annaroad Newborn Disease Screening Product Offered
Table 115. Annaroad Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Annaroad Main Business
Table 117. Annaroad Latest Developments
Table 118. Jiajian Medical Testing Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 119. Jiajian Medical Testing Newborn Disease Screening Product Offered
Table 120. Jiajian Medical Testing Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Jiajian Medical Testing Main Business
Table 122. Jiajian Medical Testing Latest Developments
Table 123. Genesky Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 124. Genesky Newborn Disease Screening Product Offered
Table 125. Genesky Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Genesky Main Business
Table 127. Genesky Latest Developments
Table 128. Weihansi Biomedical Technology Details, Company Type, Newborn Disease Screening Area Served and Its Competitors
Table 129. Weihansi Biomedical Technology Newborn Disease Screening Product Offered
Table 130. Weihansi Biomedical Technology Newborn Disease Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Weihansi Biomedical Technology Main Business
Table 132. Weihansi Biomedical Technology Latest Developments
LIST OF FIGURES
Figure 1. Newborn Disease Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Disease Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Newborn Disease Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Newborn Disease Screening Sales Market Share by Country/Region (2025)
Figure 8. Newborn Disease Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Newborn Disease Screening Market Size Market Share by Type in 2025
Figure 10. Global Newborn Disease Screening Market Size Market Share by Screening Purpose in 2025
Figure 11. Global Newborn Disease Screening Market Size Market Share by Service Model in 2025
Figure 12. Newborn Disease Screening in Public Hospitals
Figure 13. Global Newborn Disease Screening Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Newborn Disease Screening in Private Hospitals
Figure 15. Global Newborn Disease Screening Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Newborn Disease Screening in Others
Figure 17. Global Newborn Disease Screening Market: Others (2021-2026) & ($ millions)
Figure 18. Global Newborn Disease Screening Market Size Market Share by Application in 2025
Figure 19. Global Newborn Disease Screening Revenue Market Share by Player in 2025
Figure 20. Global Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Figure 21. Americas Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 22. APAC Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 23. Europe Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 25. Americas Newborn Disease Screening Value Market Share by Country in 2025
Figure 26. United States Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Newborn Disease Screening Market Size Market Share by Region in 2025
Figure 31. APAC Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 32. APAC Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 33. China Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. India Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Newborn Disease Screening Market Size Market Share by Country in 2025
Figure 40. Europe Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 41. Europe Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 42. Germany Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. France Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 56. APAC Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 57. Europe Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 59. United States Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 60. Canada Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 61. Mexico Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 62. Brazil Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 63. China Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 64. Japan Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 65. Korea Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 67. India Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 68. Australia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 69. Germany Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 70. France Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 71. UK Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 72. Italy Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 73. Russia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 74. Egypt Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 75. South Africa Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 76. Israel Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 77. Turkey Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 78. Global Newborn Disease Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Newborn Disease Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 1. Newborn Disease Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Newborn Disease Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Newborn Disease Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Newborn Disease Screening Sales Market Share by Country/Region (2025)
Figure 8. Newborn Disease Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Newborn Disease Screening Market Size Market Share by Type in 2025
Figure 10. Global Newborn Disease Screening Market Size Market Share by Screening Purpose in 2025
Figure 11. Global Newborn Disease Screening Market Size Market Share by Service Model in 2025
Figure 12. Newborn Disease Screening in Public Hospitals
Figure 13. Global Newborn Disease Screening Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Newborn Disease Screening in Private Hospitals
Figure 15. Global Newborn Disease Screening Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Newborn Disease Screening in Others
Figure 17. Global Newborn Disease Screening Market: Others (2021-2026) & ($ millions)
Figure 18. Global Newborn Disease Screening Market Size Market Share by Application in 2025
Figure 19. Global Newborn Disease Screening Revenue Market Share by Player in 2025
Figure 20. Global Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Figure 21. Americas Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 22. APAC Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 23. Europe Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Newborn Disease Screening Market Size 2021-2026 ($ millions)
Figure 25. Americas Newborn Disease Screening Value Market Share by Country in 2025
Figure 26. United States Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Newborn Disease Screening Market Size Market Share by Region in 2025
Figure 31. APAC Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 32. APAC Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 33. China Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. India Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Newborn Disease Screening Market Size Market Share by Country in 2025
Figure 40. Europe Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 41. Europe Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 42. Germany Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. France Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Newborn Disease Screening Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Newborn Disease Screening Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Newborn Disease Screening Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Newborn Disease Screening Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 56. APAC Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 57. Europe Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 59. United States Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 60. Canada Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 61. Mexico Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 62. Brazil Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 63. China Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 64. Japan Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 65. Korea Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 67. India Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 68. Australia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 69. Germany Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 70. France Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 71. UK Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 72. Italy Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 73. Russia Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 74. Egypt Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 75. South Africa Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 76. Israel Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 77. Turkey Newborn Disease Screening Market Size 2027-2032 ($ millions)
Figure 78. Global Newborn Disease Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Newborn Disease Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Newborn Disease Screening Market Size 2027-2032 ($ millions)
